Skip to content
SEC Form 4insider transactionsfree

AbbVie Inc. insider buying and selling

4 Form 4 filings against AbbVie Inc. (ABBV) in the last 90 days. Below are the transactions from 4 recent filings, one per insider where the window allows, as filed.

Window 2026-08-22 to 2026-11-20CIK 0001551152newest filing 2026-11-18source: SEC EDGAR, Form 4 XML
DateInsider and roleTransactionCodeSharesPriceOwned after
2026-11-16SALEKI AZITAEVP, CHIEF OPERATIONS OFFICERoption exerciseM23,935$61.36221,729
2026-11-16SALEKI AZITAEVP, CHIEF OPERATIONS OFFICERtax withholdingF13,481$298.55208,248
2026-11-12Stewart Jeffrey RyanEVP, CHIEF COMMERCIAL OFFICERgiftG3,45079,721
2026-11-09Stewart Jeffrey RyanEVP, CHIEF COMMERCIAL OFFICERoption exerciseM16,070$114.3699,241
2026-11-09Stewart Jeffrey RyanEVP, CHIEF COMMERCIAL OFFICERoption exerciseM24,549$93.50123,790
2026-11-09Stewart Jeffrey RyanEVP, CHIEF COMMERCIAL OFFICERopen-market saleS40,619$293.6083,171

What the filings show

Across the 4 filings read here, 2 insiders at AbbVie Inc. (ABBV) filed; 1 of them traded on the open market and reported 1 open-market sale of 40,619 shares worth about $11.9M.

The largest by value was Stewart Jeffrey Ryan (EVP, CHIEF COMMERCIAL OFFICER), with about $11.9M sold on the open market.

Transaction codes: P is an open-market purchase, S an open-market sale, A a grant or award, M an option exercise, F shares surrendered for tax. 0 open-market buys and 1 open-market sale in the rows above.
free alert

Free. One email a day at most, only when something changes. Confirm by email first; unsubscribe with one click. Privacy.

The Form 4 flow against AbbVie Inc., parsed and explained

The free view above is the newest few filings. The paid report reads the newest Form 4 filings of the last 90 days (up to 100), separates open-market buys and sales from awards, exercises and tax withholding, totals the flow per insider, flags 10b5-1 plans where the filing notes them, and hands you a cited write-up plus a downloadable transactions table.

agents: POST /v1/insider-report with {"ticker":"ABBV"} over x402 or MPP, $0.60

Sample output and API docsall reports

Generated from public SEC EDGAR filings. Filing data is shown as filed. This is information, not investment advice.